
A retrospective study aimed to describe the characteristics of contemporary pathways leading to the diagnosis of wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) and its potential association with survival. The diagnostic pathway leading to ATTRwt-CA diagnosis was heart failure (HF) in 51% of patients. Patients in the HF pathway had a worse clinical profile and outcome than those diagnosed due to suspected hypertrophic cardiomyopathy or incidentally. However, prognosis remained primarily related to age, NYHA functional class, and comorbidities rather than the diagnostic pathway. The study suggests that a better characterization of pathways leading to ATTRwt-CA diagnosis is important for disease course and prognosis.
Like
Save
Share